Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Lynne Fitzpatrick is President and CFO at CME Group. OQRO lists 8 transactions filed with the SEC under this name, the latest on Sep 17, 2026, each linked to the official Form 4.
President and CFO
Disclosures on record
8
Companies involved
1
As of the latest filing on , Lynne Fitzpatrick reported holding 26,661 shares of CME Group (CME), worth about $8.2M at the last close of $308 (Nov 20, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| CME Group CME | 26,661 | 27K direct | $308 | $8.2M | Sep 16, 2026 |
Is this Lynne Fitzpatrick’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
CME GroupCME
8 disclosures · Mar 2026 – Sep 2026
Sep 15, 20264,088disclosed Sep 17
DetailsOfficial recordSep 15, 2026249disclosed Sep 17
DetailsOfficial recordSep 15, 2026275disclosed Sep 17
DetailsOfficial recordSep 15, 2026457disclosed Sep 17
DetailsOfficial recordSep 16, 2026359disclosed Sep 17
DetailsOfficial recordMar 15, 20265,504disclosed Mar 17
DetailsOfficial recordMar 15, 20262,439disclosed Mar 17
DetailsOfficial recordMar 15, 202676disclosed Mar 17
DetailsOfficial recordLynne Fitzpatrick has no open-market purchase on record since 2024. Sales in 1 of the 3 years since 2024.
Lynne Fitzpatrick reported 0 open-market purchases and 1 sale since 2024; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2024 | — | $164K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Lynne Fitzpatrick reported 0 open-market purchases and 1 sale here, 2024.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Sep 16, 2026, Lynne Fitzpatrick reported holding 26,661 shares of CME Group (CME). At the last close of $308 on Nov 20, 2026, that is about $8.2M. This is the stake disclosed in filings, not a net worth.
No public filing gives Lynne Fitzpatrick's net worth. What SEC Form 4 shows is the stock stake: 26,661 shares of CME Group (CME), about $8.2M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Lynne Fitzpatrick has no open-market purchase on record since 2024. Sales in 1 of the 3 years since 2024.
In SEC filings since 2024: no open-market purchase is on record; the latest open-market sale is from 2024.
CME Group (CME), from 2024 to 2024: 0 purchases and 1 sale.